https://bioinformatics.umg.eu/onkopus/drugon#immunologicalagentinterleukininhibitor

Properties

label
[] immunological agent--interleukin inhibitor

Parents

Children

Relations

is_kegg_group
depemokimab
is_kegg_class
nemolizumab
is_kegg_class
ustekinumab
is_kegg_group
afasevikumab
is_kegg_group
daclizumab
is_kegg_group
spesolimab
is_kegg_class
mirikizumab
is_kegg_group
itepekimab
is_kegg_class
benralizumab
is_kegg_group
mepolizumab
is_kegg_group
reslizumab
is_kegg_class
reslizumab
is_kegg_group
rilonacept
is_kegg_class
anakinra
is_kegg_group
anrukinzumab
is_kegg_group
sirukumab
is_kegg_class
bimekizumab
is_kegg_group
risankizumab
is_kegg_group
siltuximab
is_kegg_group
isunakinra
is_kegg_class
brodalumab
is_kegg_class
sarilumab
is_kegg_group
lebrikizumab
is_kegg_group
canakinumab
is_kegg_group
benralizumab
is_kegg_group
fezakinumab
is_kegg_class
mepolizumab
is_kegg_group
tibulizumab
is_kegg_class
spesolimab
is_kegg_group
tocilizumab
is_kegg_class
tralokinumab
is_kegg_group
secukinumab
is_kegg_group
sarilumab
is_kegg_class
siltuximab
is_kegg_class
pirfenidone
is_kegg_group
lisofylline
is_kegg_group
anakinra
is_kegg_class
tildrakizumab
is_kegg_group
ustekinumab
is_kegg_group
tozorakimab
is_kegg_group
basiliximab
is_kegg_group
bimekizumab
is_kegg_class
secukinumab
is_kegg_class
risankizumab
is_kegg_group
etokimab
is_kegg_group
apilimodmesylate
is_kegg_group
mirikizumab
is_kegg_class
ixekizumab
is_kegg_group
brodalumab
is_kegg_group
antithymocyteimmunoglobulinrabbit
is_kegg_class
guselkumab
is_kegg_group
guselkumab
is_kegg_group
pirfenidone
is_kegg_group
tildrakizumab
is_kegg_group
dupilumab
is_kegg_group
lutikizumab
is_kegg_class
satralizumab
is_kegg_group
izokibep
is_kegg_class
rilonacept
is_kegg_group
lusvertikimab
is_kegg_group
tralokinumab
is_kegg_group
ordesekimab
is_kegg_class
basiliximab
is_kegg_group
enokizumab
is_kegg_group
ixekizumab
is_kegg_class
tocilizumab
is_kegg_group
olokizumab
is_kegg_class
antithymocyteimmunoglobulinrabbit
is_kegg_group
nemolizumab
is_kegg_class
dupilumab
is_kegg_group
briakinumab
is_kegg_group
brazikumab
is_kegg_group
gevokizumab
is_kegg_group
satralizumab
is_kegg_class
canakinumab